title: Hypertrophy of the tongue associated with inhaled corticosteroid therapy in premature infants.
abstract: We describe three infants in whom hypertrophy of the tongue developed while they were receiving beclomethasone inhalation therapy. The condition resolved after cessation of treatment, an outcome suggesting that tongue hypertrophy is a possible side effect of this therapy.
authors.affiliation: Department of Neonatology, Tel Aviv University, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
authors.forename: N
authors.initials: N
authors.lastname: Linder
authors.forename: J
authors.initials: J
authors.lastname: Kuint
authors.forename: B
authors.initials: B
authors.lastname: German
authors.forename: D
authors.initials: D
authors.lastname: Lubin
authors.forename: R
authors.initials: R
authors.lastname: Loewenthal
mesh_terms: D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D001997:Bronchopulmonary Dysplasia / Q000188:drug therapy; D003907:Dexamethasone / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006984:Hypertrophy / Q000209:etiology; D007231:Infant, Newborn; D007234:Infant, Premature; D008297:Male; D014059:Tongue / Q000473:pathology*
chemical_list: D000305:Adrenal Cortex Hormones; D003907:Dexamethasone